tiprankstipranks
Trending News
More News >

Kathleen D. Scott Insider Profile

4 Followers
Kathleen D. Scott, Director at Histogen, holds ― shares in Histogen (Ticker: HSTOQ), holds 13.20K shares in ARS Pharmaceuticals (Ticker: SPRY), holds 29.58K shares in Dermata Therapeutics (Ticker: DRMA). Most recently, Kathleen D. Scott ― shares of Histogen on ― for an estimated value of ―.
tipranks
Kathleen D. Scott

Kathleen D. Scott
Histogen (HSTOQ)
Director

Not Ranked
Kathleen D. Scott has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$179K
80.00%
20.00%
0.00%
0.00%
A breakdown of Kathleen D. Scott's holdings

Insider Roles

ARS Pharmaceuticals
(SPRY)
CFO
Dermata Therapeutics
(DRMA)
Director
Histogen
(HSTOQ)
Director
NKGen Biotech
(NKGN)
Director
Roles that Kathleen D. Scott holds in companies

Most Profitable Insider Trade

Stock:
ARS Pharmaceuticals
(SPRY)
Rating:Informative Buy
Date:Dec 01, 2022 - Dec 01, 2023
Return:-23.60%
The most profitable trade made by Kathleen D. Scott

Kathleen D. Scott's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Histogen
Director
Dermata Therapeutics
Oct 07, 2022
Director
Uninformative Buy
$35.80K
ARS Pharmaceuticals
Oct 17, 2024
CFO
Uninformative Buy
18.75K
$143.21K
NKGen Biotech
Director
List of latest transactions for each holding click on a transaction to see Kathleen D. Scott's performance on stock

Kathleen D. Scott insider profile FAQ

What is the percentage of profitable transactions made by Kathleen D. Scott?
The percentage of profitable transactions made by Kathleen D. Scott is ―.
    What is the average return per transaction made by Kathleen D. Scott?
    The average return per transaction made by Kathleen D. Scott is ―.
      What stocks does Kathleen D. Scott hold?
      Kathleen D. Scott holds: HSTOQ, DRMA, SPRY, NKGN stocks.
        What was Kathleen D. Scott’s latest transaction?
        Kathleen D. Scott latest transaction was an Uninformative Buy of ―.
          What was Kathleen D. Scott's most profitable transaction?
          Kathleen D. Scott’s most profitable transaction was an Informative Buy of SPRY stock on December 1, 2022. The return on the trade was -23.60%.
            What is Kathleen D. Scott's role in Histogen?
            Kathleen D. Scott's role in Histogen is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.